GlassScriptPhysician profile
Abdala Sirajeldin
NPI 1649634262
$1,556.44
in general payments reported to CMS, 2019-2025
14 companies · $785 in 2025
The $785 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2022: $24.07 · 2023: $138 · 2024: $447 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $401.78 | 2019-2025 | Lensx, Argos, Rocklatan |
| Abbvie INC. | $291.92 | 2024-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $215.84 | 2024-2025 | Catalys System, Tecnis Iol |
| Regeneron Healthcare Solutions, INC. | $125.65 | 2023-2025 | Eylea, Eylea Hd |
| Sight Sciences, INC. | $105.18 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Rxsight INC | $99.77 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Tarsus Pharmaceuticals, INC. | $76.92 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $67.45 | 2023-2025 | Cequa |
| Nova Eye, INC. | $55.94 | 2025 | |
| Biotissue Holdings INC. | $39.53 | 2025 | |
| Allergan, INC. | $24.07 | 2022 | |
| Rayner Intraocular Lenses Limited | $20.58 | 2025 | Rayone Aspheric, Rayner Cataract Set 1, Rayone Emv |
| New World Medical,INC. | $18.22 | 2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Via360 |
| Horizon Therapeutics Plc | $13.59 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdala Sirajeldin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.